Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Revenue

Kymera Therapeutics had revenue of $2.76M in the quarter ending September 30, 2025, a decrease of -26.12%. This brings the company's revenue in the last twelve months to $43.73M, down -50.05% year-over-year. In the year 2024, Kymera Therapeutics had annual revenue of $47.07M, down -40.11%.

• Revenue (ttm): $43.73M
• Revenue Growth: -50.05%
• P/S Ratio: 136.35
• Revenue / Employee: $194,378
• Employees: 225
• Market Cap: 5.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	47.07M	-31.52M	-40.11%
Dec 31, 2023	78.59M	31.77M	67.84%
Dec 31, 2022	46.83M	-26.01M	-35.71%
Dec 31, 2021	72.83M	38.80M	114.00%
Dec 31, 2020	34.03M	31.10M	1,059.99%
Dec 31, 2019	2.93M	-	-
Dec 31, 2018	2.93M	-	-